~~<i id='E1F4CE36C6'><strike id='E1F4CE36C6'><tt id='E1F4CE36C6'><pre id='E1F4CE36C6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

leisure time

author：comprehensive 2025-09-30 00:46:13 - browse：66

Photo illustration of a single pill on a large white field – opinion coverage from STAT — Adobe

This time last year, members of Congress were working around the clock to draft and pass the Inflation Reduction Act.

One of their goals was to address government spending on health care. But they specifically didn’t want to discourage research into rare disease treatments, so they exempted some of these so-called orphan drugs from the law.

Unfortunately, the exemptions aren’t working as intended. Unless Congress acts, the IRA threatens to unravel one of America’s greatest medical and public policy success stories: the explosion of new treatments for patients living with rare diseases.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Heat waves linked to early deliveries, preterm births in new study

leisure time

hotspot

knowledge

hotspot

knowledge

hotspot

Advancesingenetherapycouldeventually"cure"manyformsofcongenitaldeafness.Thechangeshavemanydeafpeople

WSS

Addiction doctors spar with methadone clinics over legislation

SCOTUS to consider access to abortion pill mifepristone

Roche to buy Carmot Therapeutics, developer of obesity drugs

Why sickle cell disease is getting the first CRISPR treatment

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Stigma and the return of syphilis

entertainment

leisure time

leisure time

How to save PrEP access — and even expand it

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

23andMe had bad news about my health. I wish a person had delivered it

SCOTUS to consider access to abortion pill mifepristone

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

SCOTUS to consider access to abortion pill mifepristone

The cancer drug shortage isn’t new — and neither are the solutions

Congenital heart disease patients face new threat of heart failure

What does generative AI mean for health care? We asked experts

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

hotspot

After sickle

Why sickle cell disease is getting the first CRISPR treatment

Focused ultrasound for uterine fibroids: an uphill battle

Leukemia patients are helped by Syndax's new type of therapy

Heat waves linked to early deliveries, preterm births in new study

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

knowledge

hotspot

knowledge

hotspot